Cargando…
Targeted delivery of liposomal chemoimmunotherapy for cancer treatment
Chemoimmunotherapy that utilizes the immunomodulatory effect of chemotherapeutics has shown great promise for treating poorly immunogenic solid tumors. However, there remains a significant room for improving the synergy between chemotherapy and immunotherapy, including the efficient, concurrent deli...
Autores principales: | Liu, Yusheng, Han, Joonsu, Bo, Yang, Bhatta, Rimsha, Wang, Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626969/ https://www.ncbi.nlm.nih.gov/pubmed/36341415 http://dx.doi.org/10.3389/fimmu.2022.1010021 |
Ejemplares similares
-
In Situ Dendritic Cell Recruitment and T Cell Activation for Cancer Immunotherapy
por: Han, Joonsu, et al.
Publicado: (2022) -
Metabolic glycan labeling immobilizes dendritic cell membrane and enhances antitumor efficacy of dendritic cell vaccine
por: Han, Joonsu, et al.
Publicado: (2023) -
Thermosensitive Exosome–Liposome Hybrid Nanoparticle‐Mediated Chemoimmunotherapy for Improved Treatment of Metastatic Peritoneal Cancer
por: Lv, Qijun, et al.
Publicado: (2020) -
Neoadjuvant immunotherapy and chemoimmunotherapy for stage II-III muscle invasive bladder cancer
por: Chen, Hualin, et al.
Publicado: (2022) -
A Review on Nano-Based Drug Delivery System for Cancer Chemoimmunotherapy
por: Mu, Weiwei, et al.
Publicado: (2020)